Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)

Thorax. 2022 Jan;77(1):79-81. doi: 10.1136/thoraxjnl-2021-217362. Epub 2021 Jun 4.

Abstract

Patients suspected of ventilator-associated lower respiratory tract infections (VA-LRTIs) commonly receive broad-spectrum antimicrobial therapy unnecessarily. We tested whether exhaled breath analysis can discriminate between patients suspected of VA-LRTI with confirmed infection, from patients with negative cultures. Breath from 108 patients suspected of VA-LRTI was analysed by gas chromatography-mass spectrometry. The breath test had a sensitivity of 98% at a specificity of 49%, confirmed with a second analytical method. The breath test had a negative predictive value of 96% and excluded pneumonia in half of the patients with negative cultures. Trial registration number: UKCRN ID number 19086, registered May 2015.

Keywords: assisted ventilation; critical care; pneumonia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breath Tests
  • Diagnostic Tests, Routine
  • Exhalation
  • Humans
  • Pneumonia, Ventilator-Associated*
  • Respiratory Tract Infections* / diagnosis
  • Ventilators, Mechanical